BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8034073)

  • 1. Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction.
    Filicori M; Flamigni C; Cognigni G; Dellai P; Michelacci L; Arnone R
    Fertil Steril; 1994 Aug; 62(2):279-85. PubMed ID: 8034073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.
    Fulghesu AM; Angioni S; Belosi C; Apa R; Selvaggi L; Ciampelli M; Iuculano A; Melis GB; Lanzone A
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-D and 3-D ultrasonographic characteristics of the ovary in women with PCOS and multifollicular ovaries.
    Bozkurt M; Kara Bozkurt D; Kurban D; Takmaz T; Sevket O; Ozcan P
    J Obstet Gynaecol; 2021 Aug; 41(6):920-926. PubMed ID: 33064032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study.
    Fulghesu AM; Ciampelli M; Belosi C; Apa R; Guido M; Caruso A; Mancuso S; Lanzone A
    J Endocrinol Invest; 2001; 24(7):483-90. PubMed ID: 11508781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
    Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
    Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and GH secretion in adolescent girls with irregular cycles: polycystic vs multifollicular ovaries.
    Villa P; Rossodivita A; Fulghesu AM; Cucinelli F; Barini A; Apa R; Belosi C; Lanzone A
    J Endocrinol Invest; 2003 Apr; 26(4):305-11. PubMed ID: 12841537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
    Tan SL; Farhi J; Homburg R; Jacobs HS
    Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone.
    Schachter M; Balen AH; Patel A; Jacobs HS
    Gynecol Endocrinol; 1996 Oct; 10(5):327-35. PubMed ID: 8915662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of insulin in ovarian size in patients with the polycystic ovary syndrome.
    Markussis V; Goni MH; Tolis G
    Gynecol Endocrinol; 1994 Sep; 8(3):197-202. PubMed ID: 7847105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles.
    Filicori M; Flamigni C; Dellai P; Cognigni G; Michelacci L; Arnone R; Sambataro M; Falbo A
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1215-20. PubMed ID: 7962297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.
    Corenthal L; Von Hagen S; Larkins D; Ibrahim J; Santoro N
    Fertil Steril; 1994 Jun; 61(6):1027-33. PubMed ID: 8194612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome.
    Fulghesu AM; Villa P; Pavone V; Guido M; Apa R; Caruso A; Lanzone A; Rossodivita A; Mancuso S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):644-8. PubMed ID: 9024269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of follicular vascularization in normal versus polycystic ovaries during in vitro fertilization as measured using 3-dimensional power Doppler ultrasonography.
    Järvelä IY; Sladkevicius P; Kelly S; Ojha K; Campbell S; Nargund G
    Fertil Steril; 2004 Nov; 82(5):1358-63. PubMed ID: 15533360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.
    Adams J; Franks S; Polson DW; Mason HD; Abdulwahid N; Tucker M; Morris DV; Price J; Jacobs HS
    Lancet; 1985 Dec 21-28; 2(8469-70):1375-9. PubMed ID: 2867389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome.
    Kaltsas T; Pontikides N; Krassas GE; Seferiadis K; Lolis D; Messinis IE
    Hum Reprod; 1998 Jan; 13(1):22-6. PubMed ID: 9512222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; Vandekerckhove P; Lilford R; van Der Veen F
    Cochrane Database Syst Rev; 2000; (2):CD000412. PubMed ID: 10796718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.